Fundz
Real-time · AI · Cross-signal

Gf Biochemicals just raised. Here's exactly what to do next.

Who to reach, what to say, and why now — on Gf Biochemicals, plus every funding round, exec hire, and M&A move that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo

Everyone else gives you a piece

✕Crunchbase & PitchBook list the company — No person, no timing, no opener.
✕ZoomInfo & Apollo sell you a contact — No trigger, no reason to reach out now.
✕LinkedIn Sales Navigator shows you people — No real-time signal, no opener.
✕Clay enriches lists you built — No live signal of its own, no who or when.
✕ChatGPT & gen-AI tools answer on a delay — No live data, no verified contact.
Who to contactWhat to sayWhen to reach outWhy now

Only Fundz delivers all four.

Gfbiochemicals Raises €15M Series A To Advance Its Mission To End Chemical Pollution

PRIVATEMay 05, 2022•about 4 years ago

Amount Raised

€15 Million

Round Type

series a

Paris

Description

PARIS, FRANCE / May 5, 2022 / GFBiochemicals, a leading sustainable chemical company, today announced a €15 million Series A funding round led by Sofinnova Partners, with participation from Sparta Capital. At a time when the chemical crisis has already passed the safe limit for human health and the environment, the round will accelerate GFBiochemicals' mission to end chemical pollution. The company aims to help fast moving consumer goods (FMCG) and industrial companies transition away from using toxic, environmentally harmful petrochemicals in everyday products.

Company Information

Company

Gf Biochemicals

Location

Paris, Ile De France, France

About

Headquartered in Paris, GFBiochemicals is a leading sustainable chemical company with a mission to end chemical pollution. We provide the companies who make our everyday products with safe, sustainable solvents and ingredients derived from the biobased levulinic molecule. This has three benefits: it ensures that everyday products are biodegradable, non-harmful and carbon friendly. GFBiochemicals has offices and R&D facilities in the Netherlands and the United States, operations in India, and over 200 active patents across 40 patent families. Through our Joint Venture, NXTLEVVEL, we leverage our proprietary technology to enable commercial-scale manufacturing of our product. For more information, please visit: http://www.gfbiochemicals.com/company/.

Predictive Intelligence
Strategic

ML-powered predictions for Gf Biochemicals's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies.

Watching Gf Biochemicals? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demoChoose your plan